Breast Cancer Clinical Trials in Glendale, AZ

Breast Cancer Clinical Trials in Glendale, AZ

View the best 10 breast cancer medical studies in Glendale, Arizona. Access promising new therapies by applying to a Glendale-based Breast Cancer clinical trial.

Top rated breast cancer clinical trials in Glendale, Arizona

Here are the top 10 medical studies for breast cancer in Glendale, Arizona

Image of University of Alabama at Birmingham in Birmingham, United States.

Abemaciclib

CDK4/6 Inhibitor

Recruiting1 awardPhase 3
This trial is testing abemaciclib as a treatment for early breast cancer in people who are also taking hormone therapy. It will last up to 10 years.
Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Doxorubicin Hydrochloride +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is testing two different chemotherapy combinations to treat triple negative breast cancer to see which is more effective.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Surgery +2 More

Procedure

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding stereotactic radiosurgery and/or surgery to standard of care therapy is more effective in treating patients with limited metastatic breast cancer.
Image of Northwestern Medicine Cancer Center in Warrenville, United States.

TOL2506

Hormone Therapy

Recruiting2 awardsPhase 3
This trial is testing a new drug to suppress ovarian function in premenopausal women with breast cancer. The study will also assess the safety of the drug in men with breast cancer.
Image of Dignity Health St Joseph's Hospital and Medical Center in Phoenix, United States.

Entrectinib

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug, entrectinib, for patients with different types of solid tumors that have a gene fusion. Patients will be assigned to different groups depending on their tumor type and gene fusion.
Image of Arizona Oncology Associates, PC - HAL in Phoenix, United States.

Tucatinib +2 More

Small Molecule Kinase Inhibitor

Recruiting1 awardPhase 2
This trial is for people with solid tumors that make too much HER2 or a different type of HER2. Participants will get tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get fulvestrant. The trial will look at side effects.
Image of Banner Health/Banner Research in Phoenix, United States.

Quality-of-Life Assessment

Recruiting1 award3 criteria
This trial is testing whether eliminating surgery and just using radiation therapy after systemic therapy works well in treating patients with HER2 positive or triple negative breast cancer.
Image of Mobile Infirmary Medical Center in Mobile, United States.

Cisplatin +1 More

Platinum-based Chemotherapy

Recruiting3 awardsPhase 3
This trial is comparing two types of chemotherapy drugs to see which is more effective in treating patients with residual triple negative basal-like breast cancer.
Image of Honor Health in Phoenix, United States.

AMXI-5001

Chemotherapy

Recruiting1 awardPhase 1 & 2
This trial is testing a new cancer treatment called AMXI-5001 in adults who have unsuccessfully tried other treatments. The study has two parts: first, they're testing different doses to see what is safe and effective; second, they're expanding the study to see how well the treatment works.
Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Olaparib +1 More

PARP Inhibitor

Recruiting1 awardPhase 2
This trial is testing olaparib with or without atezolizumab to treat non-HER2-positive breast cancer that has spread and is not able to be surgically removed or has metastasized.

Popular filter options for breast-cancer glendale trials

Phase 3 Clinical Trials

View 98 phase 3 medical studies.

Clinical Trials With No Placebo

View 98 medical studies that do not have a placebo group.

View More Breast-cancer Glendale Trials

See another 81 medical studies focused on breast-cancer glendale.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.